Profile data is unavailable for this security.
About the company
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.
- Revenue in HKD (TTM)2.84bn
- Net income in HKD448.13m
- Incorporated2007
- Employees2.16k
- LocationShanghai Haohai Biological Technology Co Ltd4F, No 2 Building, Alley 139Anshun Road, Changning DistrictSHANGHAI 200336ChinaCHN
- Phone+86 2 152293555
- Fax+86 2 152293558
- Websitehttps://www.3healthcare.com/
Mergers & acquisitions
Acquired company | 6826:HKG since announced | Transaction value |
---|---|---|
OHMK Medical Technology Co Ltd | -12.29% | 21.36m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Micro-Tech Nanjing Co Ltd | 2.67bn | 568.28m | 13.45bn | 2.40k | 23.65 | 3.35 | -- | 5.04 | 2.81 | 2.81 | 13.23 | 19.86 | 0.5948 | 1.62 | 6.91 | 1,032,216.00 | 12.91 | 10.74 | 14.98 | 12.82 | 64.81 | 63.04 | 21.71 | 19.37 | 5.19 | -- | 0.01 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
Shenzhen YHLO Biotech Co Ltd | 1.96bn | 365.80m | 13.94bn | 1.76k | 38.18 | 4.92 | -- | 7.10 | 0.5956 | 0.5956 | 3.21 | 4.62 | 0.4798 | 1.11 | 4.91 | 1,037,196.00 | 7.03 | 16.43 | 9.12 | 24.16 | 62.14 | 53.26 | 14.66 | 20.01 | 1.50 | -- | 0.1872 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.36bn | 594.10m | 14.44bn | 908.00 | 22.19 | 3.32 | -- | 10.65 | 4.91 | 4.91 | 11.27 | 32.80 | 0.3769 | 1.60 | 7.96 | 1,387,329.00 | 16.35 | 17.68 | 18.12 | 19.43 | 75.61 | 76.60 | 43.39 | 42.25 | 9.49 | -- | 0.008 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
Shanghai Haohai Biological Technology | 2.84bn | 448.13m | 14.99bn | 2.16k | 11.95 | 0.9234 | 22.82 | 5.28 | 2.63 | 2.63 | 16.64 | 34.01 | 0.3765 | 1.55 | 7.50 | 1,314,926.00 | 5.89 | 4.84 | 6.86 | 5.50 | 70.34 | 72.09 | 15.65 | 16.50 | 4.50 | -- | 0.0635 | 36.86 | 25.27 | 11.26 | 130.58 | 0.0762 | 11.96 | 14.22 |
Beijing Balance Medical Technolgy Co Ltd | 411.23m | 120.38m | 15.42bn | 473.00 | 129.13 | 11.87 | -- | 37.51 | 0.8125 | 0.8125 | 2.78 | 8.84 | 0.3061 | 1.06 | 5.72 | 807,636.20 | 8.16 | 8.06 | 8.48 | 8.40 | 89.40 | 89.41 | 26.67 | 30.02 | 9.77 | -- | 0.0094 | 69.19 | 25.57 | 27.35 | 21.09 | 28.10 | 125.94 | -- |
Eyebright Medical Tchnlgy Beijing Co Ltd | 1.15bn | 353.61m | 15.47bn | 2.07k | 43.86 | 6.49 | -- | 13.41 | 1.73 | 1.73 | 5.64 | 11.69 | 0.4003 | 1.99 | 5.19 | 516,774.60 | 11.51 | 9.99 | 13.27 | 11.16 | 72.24 | 81.29 | 28.74 | 34.66 | 2.48 | -- | 0.1339 | 19.91 | 64.14 | 49.59 | 30.63 | 71.80 | 38.83 | -- |
Top Glove Corporation Bhd | 3.39bn | -1.16bn | 15.90bn | 10.00k | -- | 1.62 | -- | 4.68 | -0.0876 | -0.0876 | 0.256 | 0.7234 | 0.2811 | -- | 8.11 | 128,154.80 | -9.05 | 24.37 | -10.39 | 31.04 | -- | 43.76 | -32.20 | 25.88 | 1.49 | -61.54 | 0.0874 | 70.79 | -59.49 | -11.77 | -510.18 | -- | -4.47 | -- |
Poly Medicure Ltd. | 1.29bn | 241.43m | 17.81bn | 2.34k | 73.84 | 12.96 | 59.14 | 13.85 | 26.89 | 26.89 | 143.25 | 153.18 | 0.8008 | 2.25 | 5.44 | -- | 15.03 | 13.16 | 18.50 | 16.12 | 64.92 | 58.11 | 18.77 | 16.69 | 1.77 | 33.54 | 0.1059 | 15.10 | 23.36 | 17.63 | 44.05 | 31.61 | 28.85 | 8.45 |
Holder | Shares | % Held |
---|---|---|
Prudence Investment Management (Hong Kong) Ltd.as of 30 Jun 2023 | 1.97m | 6.65% |
Kabouter Management LLCas of 14 Oct 2022 | 1.48m | 5.00% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.43m | 4.84% |
GF Fund Management Co., Ltd.as of 13 Nov 2023 | 1.39m | 4.71% |
The Vanguard Group, Inc.as of 06 Jun 2024 | 1.31m | 4.42% |
Templeton Investment Counsel LLCas of 14 Oct 2022 | 1.21m | 4.09% |
Dalton Investments LLCas of 26 Oct 2022 | 1.16m | 3.90% |
Dimensional Fund Advisors LPas of 06 Jun 2024 | 261.36k | 0.88% |
E Fund Management (Hong Kong) Co., Ltd.as of 30 Jun 2023 | 233.60k | 0.79% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 165.90k | 0.56% |